biostudies-literatureUnknown85(17)Edelvik A<h4>Objective</h4>To investigate long-term employment outcomes after resective epilepsy surgery in a national population-based cohort of adults.<h4>Methods</h4>In the Swedish National Epilepsy Surgery Register, all adults who were operated with resective epilepsy surgery from 1995 to 2010 were identified. Two-year follow-up was available for 473/496, 5-year follow-up for 220/240, 10-year follow-up for 240/278, and 15-year follow-up for 85/109 patients.<h4>Results</h4>There were no significant changes in employment outcome over time at group level, but for those with full-time employment at baseline, 79%, 79%, 57%, and 47% of seizure-free patients were in full-time work at 2-, 5-, 10-, and 15-year follow-up, compared to patients with benefits at baseline, where 16%, 27%, 31%, and 33% of seiNeurology1482-90https://www.ebi.ac.uk/biostudies/studies/S-EPMC4631069biostudies-literatureProspective and longitudinal long-term employment outcomes after resective epilepsy surgery.PMC4631069Malmgren KFlink REdelvik AfalseProspective and longitudinal long-term employment outcomes after resective epilepsy surgery.<h4>Objective</h4>To investigate long-term employment outcomes after resective epilepsy surgery in a national population-based cohort of adults.<h4>Methods</h4>In the Swedish National Epilepsy Surgery Register, all adults who were operated with resective epilepsy surgery from 1995 to 2010 were identified. Two-year follow-up was available for 473/496, 5-year follow-up for 220/240, 10-year follow-up for 240/278, and 15-year follow-up for 85/109 patients.<h4>Results</h4>There were no significant changes in employment outcome over time at group level, but for those with full-time employment at baseline, 79%, 79%, 57%, and 47% of seizure-free patients were in full-time work at 2-, 5-, 10-, and 15-year follow-up, compared to patients with benefits at baseline, where 16%, 27%, 31%, and 33% of sei2015-01-01T00:00:00Z2015 Oct2025-04-06T19:44:42.988Z2019-03-27T02:01:14ZS-EPMC46310692640849010.1212/WNL.0000000000002069